ATE444076T1 - Verwendung von botulintoxin zur linderung von hodenschmerzen - Google Patents

Verwendung von botulintoxin zur linderung von hodenschmerzen

Info

Publication number
ATE444076T1
ATE444076T1 AT07811857T AT07811857T ATE444076T1 AT E444076 T1 ATE444076 T1 AT E444076T1 AT 07811857 T AT07811857 T AT 07811857T AT 07811857 T AT07811857 T AT 07811857T AT E444076 T1 ATE444076 T1 AT E444076T1
Authority
AT
Austria
Prior art keywords
pain
botulintoxin
testical
relief
testicle
Prior art date
Application number
AT07811857T
Other languages
English (en)
Inventor
Gregory Brooks
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Application granted granted Critical
Publication of ATE444076T1 publication Critical patent/ATE444076T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
    • A61K38/4893—Botulinum neurotoxin (3.4.24.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT07811857T 2006-05-02 2007-04-26 Verwendung von botulintoxin zur linderung von hodenschmerzen ATE444076T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/417,335 US7811586B2 (en) 2006-05-02 2006-05-02 Methods for alleviating testicular pain
PCT/US2007/067521 WO2007143294A1 (en) 2006-05-02 2007-04-26 Use of botulinum toxin for alleviating testicular pain

Publications (1)

Publication Number Publication Date
ATE444076T1 true ATE444076T1 (de) 2009-10-15

Family

ID=38461002

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07811857T ATE444076T1 (de) 2006-05-02 2007-04-26 Verwendung von botulintoxin zur linderung von hodenschmerzen

Country Status (6)

Country Link
US (1) US7811586B2 (de)
EP (1) EP2012811B1 (de)
AT (1) ATE444076T1 (de)
DE (1) DE602007002625D1 (de)
ES (1) ES2330692T3 (de)
WO (1) WO2007143294A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9211248B2 (en) 2004-03-03 2015-12-15 Revance Therapeutics, Inc. Compositions and methods for topical application and transdermal delivery of botulinum toxins
US8105611B2 (en) * 2005-06-17 2012-01-31 Allergan, Inc. Treatment of autoimmune disorder with a neurotoxin
EP2161033B1 (de) * 2008-09-09 2013-05-01 Susanne Dr. Grafe Botulinumtoxin zur Erzeugung der zeitweisen Unfruchtbarkeit in einem Wirbeltier (z.B. beim Menschen)
RU2438594C2 (ru) * 2009-07-23 2012-01-10 Государственное образовательное учреждение высшего профессионального образования "Тверская государственная медицинская академия" Министерства здравоохранения и социального развития Российской Федерации (ГОУ ВПО Тверская ГМА Минздравсоцразвития России) Способ определения показаний к выбору метода оперативного лечения водянки оболочек яичка у детей по данным комплексного ультразвукового исследования
RU2454170C1 (ru) * 2011-02-21 2012-06-27 Федеральное государственное учреждение "Нижегородский научно-исследовательский институт травматологии и ортопедии" Министерства здравоохранения и социального развития Российской Федерации Способ лечения спастичности мышц у больных с позвоночно-спинномозговой травмой
ES2424294B1 (es) 2012-03-22 2014-07-21 Lipotec, S.A. Exopolisacárido para el tratamiento y/o cuidado de la piel, mucosas, cabello y/o uñas
EP2836193B1 (de) 2012-04-13 2018-01-31 Lubrizol Advanced Materials, Inc. Verbindungen zur hemmung neuronaler exozytose (ii)
EP2649983A1 (de) 2012-04-13 2013-10-16 Lipotec, S.A. Verbindungen zur Hemmung neuronaler Exozytose (II)
EP2649984A1 (de) 2012-04-13 2013-10-16 Lipotec, S.A. Verbindungen zur Hemmung neuronaler Exozytose
EP2649985A1 (de) 2012-04-13 2013-10-16 Lipotec, S.A. Verbindungen zur Hemmung neuronaler Exozytose (III)
CN105451710A (zh) 2013-03-22 2016-03-30 利普泰股份公司 用于治疗和/或护理皮肤、粘膜和/或指甲的外泌多糖
WO2023287726A1 (en) 2021-07-12 2023-01-19 Penland Foundation Treatment of cancer using botulinum toxin and nitrous oxide

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9120306D0 (en) 1991-09-24 1991-11-06 Graham Herbert K Method and compositions for the treatment of cerebral palsy
US5437291A (en) 1993-08-26 1995-08-01 Univ Johns Hopkins Method for treating gastrointestinal muscle disorders and other smooth muscle dysfunction
US5427291A (en) 1993-09-21 1995-06-27 Smith; David S. Ski carrier and method employing same
DE69434610T2 (de) 1993-12-28 2008-11-27 Allergan, Inc., Irvine Verwendung der neurotoxischen Komponente des Botulinum Toxins zur Behandlung von Muskelspasmen
US6974578B1 (en) 1993-12-28 2005-12-13 Allergan, Inc. Method for treating secretions and glands using botulinum toxin
US5766605A (en) 1994-04-15 1998-06-16 Mount Sinai School Of Medicine Of The City University Of New York Treatment of autonomic nerve dysfunction with botulinum toxin
PT1086702E (pt) 1994-05-09 2005-08-31 William J Binder Neurotoxinas pre-sinapticas para tratamento da dor de cabeca devida a enxaqueca
US5670484A (en) 1994-05-09 1997-09-23 Binder; William J. Method for treatment of skin lesions associated with cutaneous cell-proliferative disorders
GB9508204D0 (en) 1995-04-21 1995-06-07 Speywood Lab Ltd A novel agent able to modify peripheral afferent function
US7470431B2 (en) 1997-07-15 2008-12-30 The Regents Of The University Of Colorado Use of neurotoxin therapy for treatment of urological-neurological disorders associated with prostate cancer
US7455845B2 (en) 1997-07-15 2008-11-25 The Regents Of The University Of Colorado Use of neurotoxin therapy for treatment of urologic and related disorders related to lowering elevated bladder pressure
US9066943B2 (en) 1997-07-15 2015-06-30 The Regents Of The University Of Colorado Use of botulinum toxin therapy for treatment of urological neurological conditions
ATE339220T1 (de) 1997-07-15 2006-10-15 Univ Colorado Verwendung einer neurotoxintherapie zur behandlung der harnverhaltung
US6063768A (en) 1997-09-04 2000-05-16 First; Eric R. Application of botulinum toxin to the management of neurogenic inflammatory disorders
US6113915A (en) 1999-10-12 2000-09-05 Allergan Sales, Inc. Methods for treating pain
US6265379B1 (en) 1999-10-13 2001-07-24 Allergan Sales, Inc. Method for treating otic disorders
US6139845A (en) 1999-12-07 2000-10-31 Allergan Sales, Inc. Method for treating cancer with a neurotoxin
US6143306A (en) 2000-01-11 2000-11-07 Allergan Sales, Inc. Methods for treating pancreatic disorders
US6358513B1 (en) 2000-02-15 2002-03-19 Allergan Sales, Inc. Method for treating Hashimoto's thyroiditis
US6319506B1 (en) 2000-02-22 2001-11-20 Allergan, Sales, Inc. Method for treating hypercalcemia
US6464986B1 (en) 2000-04-14 2002-10-15 Allegan Sales, Inc. Method for treating pain by peripheral administration of a neurotoxin
US6299893B1 (en) 2000-04-17 2001-10-09 Marvin Schwartz Method to reduce hair loss and stimulate hair regrowth
US6306423B1 (en) 2000-06-02 2001-10-23 Allergan Sales, Inc. Neurotoxin implant
US6306403B1 (en) 2000-06-14 2001-10-23 Allergan Sales, Inc. Method for treating parkinson's disease with a botulinum toxin
US6423319B1 (en) 2000-10-04 2002-07-23 Allergan Sales, Inc. Methods for treating muscle injuries
US6776991B2 (en) 2002-06-26 2004-08-17 Allergan, Inc. Methods for treating priapism

Also Published As

Publication number Publication date
US20070259000A1 (en) 2007-11-08
EP2012811A1 (de) 2009-01-14
WO2007143294A1 (en) 2007-12-13
EP2012811B1 (de) 2009-09-30
DE602007002625D1 (de) 2009-11-12
ES2330692T3 (es) 2009-12-14
US7811586B2 (en) 2010-10-12

Similar Documents

Publication Publication Date Title
ATE444076T1 (de) Verwendung von botulintoxin zur linderung von hodenschmerzen
WO2007100675A3 (en) Collagenase for treating cellulite
NZ603717A (en) Suture line administration technique using botulinum toxins
WO2010017556A8 (en) Method and apparatus for fractional deformation and treatment of cutaneous and subcutaneous tissue
WO2007081757A3 (en) Total dentist
TW200503751A (en) Methods for treating sinus headache
IL249263B (en) Method for ex-vivo organ care
MY165570A (en) Inhibitors of poly (adp-ribose) polymerase
BR0308928A (pt) Uso de toxina botulìnica para o tratamento de doenças cardiovasculares, bem como composição para uso em um procedimento cardiovascular
BRPI0418745A (pt) anticorpo linhagem de células, composição farmacêutica, e, método de tratamento de cáncer em um paciente
CA2582022C (en) Methods for the administration of iloperidone
BRPI0810336A2 (pt) "método para tratar e/ou prevenir úlceras de pele em um indivíduo"
ATE456369T1 (de) Flibanserin zur behandlung von harninkontinenz und assoziierten erkrankungen
WO2009031606A1 (ja) 関節炎治療及び予防剤
WO2011146926A3 (en) Systems and methods for treatment of sleep apnea
WO2012068339A3 (en) Methods of treating cancer
AU2012366182A8 (en) Method of treating diabetes using non-glycosylated apolipoprotein A-IV
CA2899775C (en) Compositions and methods for pain relief without numbness
WO2007100590A3 (en) Methods for treating cellulite
DK1596879T3 (da) Anvendelse af kahalalidforbindelser til fremstilling af et medikament til behandling af psoriasis
DK1869185T3 (da) Konjugat med P21-protein til kræftbehandling
DK1778834T3 (da) Fremgangsmåder til anvendelse af regenerative celler i behandlingen af renale sygdomme og lidelser
UA88697C2 (ru) Способ лечения больных с ожоговыми ранами
UA39741U (uk) Спосіб проведення дренажу після операції на щитовидній залозі
Emsen Corrigendum to “A different and safe method of split thickness skin graft fixation: Medical honey application”[Burns 33 (6)(2007) 782–787]

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties